Joshua Resnick

Insider Reports History

Entity
Individual
Location
One Boston Place, 201 Washington Street, Suite 3900, Boston, MA
Signature
/s/ Noel Donnelly, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joshua Resnick:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. Director Stock Option (Right to Buy) 12.5K $205K $16.37 Jun 5, 2024 Direct
Vor Biopharma Inc. Director Stock Option (Right to Buy) 30K May 23, 2024 Direct
PepGen Inc. Director Stock Option (Right to Buy) 13K Jun 20, 2024 Direct

Insider Reports Filed by Joshua Resnick

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PEPG PepGen Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
AVTE Aerovate Therapeutics, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
VOR Vor Biopharma Inc. May 23, 2024 1 $0 4 May 28, 2024 Director
PEPG PepGen Inc. Jun 22, 2023 1 $0 4 Jun 26, 2023 Director
AVTE Aerovate Therapeutics, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
VOR Vor Biopharma Inc. May 26, 2023 1 $0 4 Jun 2, 2023 Director
AVTE Aerovate Therapeutics, Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director
VOR Vor Biopharma Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
PEPG PepGen Inc. May 6, 2022 1 $0 4 May 10, 2022 Director
PEPG PepGen Inc. May 5, 2022 0 $0 3 May 5, 2022 Director
AVTE Aerovate Therapeutics, Inc. Jun 29, 2021 1 $0 4 Jul 1, 2021 Director
AVTE Aerovate Therapeutics, Inc. Jun 29, 2021 0 $0 3 Jun 29, 2021 Director